Status:

COMPLETED

The Efficacy of Doxazosin for Cocaine Users

Lead Sponsor:

Baylor College of Medicine

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Cocaine Dependence

Eligibility:

All Genders

18-64 years

Phase:

PHASE1

Brief Summary

Doxazosin, an alpha 1-adrenergic receptor, may play an important role in cocaine addiction in humans. This study will evaluate the effectiveness of doxazosin in preventing drug relapse among cocaine d...

Detailed Description

The NE system, especially the alpha 1-adrenergic receptor, may play an important role in cocaine addiction in humans. The results of this study will provide medical safety data on the duration of the ...

Eligibility Criteria

Inclusion

  • Meets DSM-IV diagnosis criteria for cocaine dependence, as determined by self-reported use of cocaine at least once weekly for at least 1 month prior to study entry; a positive urine test for cocaine; and a score greater than 3 on the Severity of Dependence Scale
  • If female, willing to use contraception throughout the study

Exclusion

  • Meets DSM-IV diagnosis criteria for dependence on any drugs other than cocaine, or tobacco
  • Current major psychiatric illness, including schizophrenia, bipolar disorder, or other psychotic disorder
  • Current suicidal or homicidal ideation
  • Current use of a prescribed psychotropic medication that cannot be discontinued
  • History of or current major medical illness, including major heart, kidney, endocrine, or liver disorder; abnormal liver function (SGOT or SGPT levels three times greater than normal); or high blood pressure or low blood pressure
  • High risk factor for heart disease, seizure disorders, or any illness for which disulfiram or methadone treatment would be inadvisable
  • Currently taking metronidazole or clotrimazole
  • Pregnant or breastfeeding

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT00880997

Start Date

September 1 2009

End Date

December 1 2011

Last Update

August 22 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Baylor College of Medicine - Michael E. DeBakey VA Medical Center

Houston, Texas, United States, 77030